Home>>Hospital racial composition and the treatment of localized prostate cancer.

Search

About

Authors:
Address: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. cpollac2@jhmi.edu
Journal:


Publication:


abstract

BACKGROUND:

racial differences in the treatment of men with localized prostate cancer remain poorly understood. This study examines whether Hospital racial composition is associated with the type of treatment black and white men receive.

METHODS:

The authors performed a retrospective cohort study of men in Surveillance, Epidemiology, and End Results-Medicare diagnosed with localized prostate cancer from 1995 to 2005 linked to hospital and census data. A total of 134,291 men were assigned to the hospital where they received care. Generalized estimating equations were used to determine whether hospital racial composition was associated with the receipt of definitive therapy and type of treatment.

RESULTS:

Black men were less likely to receive radiation and/or prostatectomy compared with white men (55.5% vs 63.7%, P < .001) and, among those who received definitive therapy, were less likely to undergo prostatectomy (27.5% vs 31.9%, P < .001). The percentage of black men who received their care at hospitals with a high proportion of black patients was 48.0%, compared with only 5.2% of white patients who received care in this subset of hospitals. Men were significantly less likely to receive definitive treatment (odds ratio, 0.81; 95% confidence interval, 0.74-0.90) in hospitals with a high proportion of black patients compared with men seen at hospitals with fewer black patients. The association between hospital racial composition and treatment did not significantly differ by patient race.

CONCLUSIONS:

Hospital racial composition is consistently associated with the care that men receive for localized prostate cancer. Better understanding of the factors that determine where men receive care is an important component in reducing variation in treatment.

Copyright © 2011 American Cancer Society.



Related Articles
Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.
Med Care. 2011
Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.
Pollack CE, Bekelman JE, Epstein AJ, Liao K, Wong YN, Armstrong K. Med Care. 2011 Nov; 49(11):999-1006.
Do hospitals provide lower quality of care to black patients for pneumonia?
Crit Care Med. 2010
Do hospitals provide lower quality of care to black patients for pneumonia?
Mayr FB, Yende S, D'Angelo G, Barnato AE, Kellum JA, Weissfeld L, Yealy DM, Reade MC, Milbrandt EB, Angus DC. Crit Care Med. 2010 Mar; 38(3):759-65.
Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
J Natl Cancer Inst. 2003
Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA, Schenck AP, Amamoo MA, Schoenbach VJ, Peacock S, Manning M, Symons M, Talcott JA. J Natl Cancer Inst. 2003 Nov 19; 95(22):1702-10.
Review Racial differences in prostate cancer treatment outcomes: a systematic review.
Cancer Nurs. 2005
Review Racial differences in prostate cancer treatment outcomes: a systematic review.
Peters N, Armstrong K. Cancer Nurs. 2005 Mar-Apr; 28(2):108-18.
Review Disparities in diagnosis of bipolar disorder in individuals of African and European descent: a review.
J Psychiatr Pract. 2011
Review Disparities in diagnosis of bipolar disorder in individuals of African and European descent: a review.
Haeri S, Williams J, Kopeykina I, Johnson J, Newmark A, Cohen L, Galynker I. J Psychiatr Pract. 2011 Nov; 17(6):394-403.